000			03733nam a2200457Ii 4500
001			9781787565999
003			UtOrBLW
005			20210303084921.0
006			m o d
007			cr un|||||||||
008			180917s2018 enk o 001 0 eng d
020			_a9781787565999 (e-book)
040			_aUtOrBLW _beng _erda _cUtOrBLW
043			_an-us---
050		4	_aK3850 _b.H43 2018
072		7	_aKC _2bicssc
072		7	_aBUS069000 _2bisacsh
080			_a343
082	0	4	_a343.0721 _223
245	0	0	_aHealthcare antitrust, settlements, and the Federal Trade Commission / _cedited by James Langenfeld and Edwin Galeano.
264		1	_bEmerald Publishing Limited,
300			_a1 online resource (xvii, 464 pages) ; _ccm.
490	1		_aResearch in law and economics, _x0193-5895 ; _vvolume 28
500			_aIncludes index.
505	0		_aPrelims -- "To know where youre going, look at where youve been" -- Actavis, authorized generics, and the future of antitrust law -- Solving the product-hopping conundrum through safe harbors and a no-economic-sense test -- A market all its own: medicare advantage as a separate product market in the DOJs case against the Aetna-Humana Merger -- A history of the FTCs Bureau of Economics -- Labor disputes and pretrial settlements: the French case -- Franchisees facing online sales in a European legal context -- Mandatory upstream inputs and upward pricing pressure: implications for competition policy -- When is the "Kennedy Correction" appropriate in estimating overcharges? -- Kwokas mergers, merger control, and remedies: rejoinder to Kwoka -- Index.
520			_aThis volume of Research in Law and Economics contains articles that address important legal and economic developments in the areas of healthcare, intellectual property and labor settlements, competitive effects, cartel overcharges, and the U.S. Federal Trade Commission ("FTC"). Four of the articles were initially presented at a conference on healthcare competition in Washington, D.C., which was sponsored by the American Antitrust Institute, this journal, and Navigant Economics. These articles explore practices that are under challenge in pharmaceuticals, where the Federal Trade Commission has been extremely active, as well as issues involving hospital and health insurance mergers. They are followed by a long and detailed discussion of the current and historic role of economists and economic analysis at the Federal Trade Commission. The next two articles analyze different aspects of the French economy, pre-trial labor settlements and the impact of e-commerce on franchisees. The volume ends with three technical economics articles one on "upward pricing pressure", one on estimating price increases in cartel cases, and one critiquing a "meta-analysis" of research on the effectiveness of U.S. merger regulation. Taken together, these articles raise questions about appropriate competition policy, how to evaluate settlements and other firm behavior, and where economics and competition policy are headed.
588	0		_aPrint version record
650		0	_aAntitrust law _zUnited States.
650		0	_aMedical care _xLaw and legislation _zUnited States.
650		7	_aBusiness & Economics _xEconomics _xGeneral. _2bisacsh
650		7	_aEconomics. _2bicssc
700	1		_aLangenfeld, James, _eeditor.
700	1		_aGaleano, Edwin, _eeditor.
776			_z9781787566002
830		0	_aResearch in law and economics ; _vv. 28. _x0193-5895
856	4	0	_uhttps://www.emerald.com/insight/publication/doi/10.1108/S0193-5895201828
999			_c30060 _d30060